GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this double blind, placebo controlled, study is to evaluate activity consistent
with efficacy provided by 14 days administration of GI270384X, and to provide preliminary
pharmacokinetics and safety/tolerability of 14 days administration of GI270384X in patients
with mild to moderate active ulcerative colitis (UC).